Expression of EMMPRIN, MMPs and TIMP2 in retinoblastoma and normal retinal tissue

International Journal of Ophthalmology

Volumn 8, Issue 6, 2008, Pages 1079-1082

  Li, Yun ^a   Tang, Luo Sheng ^a   Zhou, Qing Hua ^a   Cao, Dan ^a   Yang, Zhu Lin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

EMMPRIN; Immunohistochemistry; MMP1; MMP9; Retinoblastoma; TIMP2

Indexed keywords

CD147 ANTIGEN; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CHILD; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; LIFESPAN; MALE; METASTASIS; OPTIC NERVE; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETINOBLASTOMA; TISSUE DIFFERENTIATION;

EID: 47249107299     PISSN: 16725123     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Wang Y, Tang XR, Lin ZS. Study on the clinical pathology of 98 cases with retinoblastoma. Fujian Med J 2000;22(4):8-9
2. Denys H, De Wever O, Nusgens B, Kong Y, Sciot R, Le AT, Van Dam K, Jadidizadeh A, Tejpar S, Mareel M, Alman B, Cassiman JJ. Invasion and MMP expression profile in desmoid tumors. Br J Cancer 2004,90(7):1443-1449
3. Przybylowska K, Zielinska J, Zadrozny M, Krawczyk T, Kulig A, Wozniak P, Rykala J, Kolacinska A, Morawiec Z, Drzewoski J, Blasiak J. An association between the matrix metalloproteinase 1 promoter gene polymorphism and lymphnode metastasis in breast cancer. J Exp Clin Cancer Res 2004;23(1):121-125
4. Görögh T, Beier UH, B umken J, Meyer JE, Hoffmann M, Gottschlich S, Maune S. Metalloproteinases and their inhibitors: influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas. Head Neck 2006;28(1):31-39
5. Aglund K, Rauvala M, Puistola U, Angstr m T, Turpeenniemi-Hujanen T, Zackrisson B, Stendahl U. Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer-MMP-9 correlates to the grade and the stage. Gynecol Oncol 2004;94(3):699-704
6. Guttman D, Stern Y, Shpitzer T, Ulanovski D, Druzd T, Feinmesser R. Expression of MMP-9, TIMP-1, CD-34 and factor-8 as prognostic markers for squamous cell carcinoma of the tongue. Oral Oncol 2004;40 (8):798-803
7. Kallakury BV, Karikehalli S, Haholu A, Sheehan CE, Azumi N, Ross JS. Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma. Clin Cancer Res 2001;7 (10): 3113-3119
8. Adithi M, Nalini V, Kandalam M, Krishnakumar S. Expression of matrix metalloproteinases and their inhibitors in retinoblastoma. J Pediatr Hematol Oncol 2007; 29(6):399-405
9. Toole BP. Emmprin (CD147), a cell surface regulator of matrix metalloproteinase production and function. Curr Top Dev Biol 2003;54: 371-389
10. Davidson B, Goldberg I, Berner A, Kristensen GB, Reich R. EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma. Clin Exp Metastasis 2003;20(2):161-169